(Q35957945)

11 August 2017

1 reference

title

Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae (English)

1 reference

11 August 2017

1 reference

Streptococcus pneumoniae

1 reference

Joseph F Plouffe

1

1 reference

PubMed ID

15555834

11 August 2017

Daniel R Martin

series ordinal

2

1 reference

PubMed ID

15555834

11 August 2017

language of work or name

1 reference

1 December 2004

1 reference

Infectious Disease Clinics of North America

11 August 2017

1 reference

11 August 2017

18

1 reference

11 August 2017

4

1 reference

11 August 2017

963-74; x-xi

1 reference

Dexamethasone in adults with bacterial meningitis

11 August 2017

1 reference

12 December 2020

Legionnaires disease with bacteremic coinfection.

1 reference

12 December 2020

Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin.

1 reference

12 December 2020

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

1 reference

12 December 2020

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

1 reference

12 December 2020

Blood cultures for community-acquired pneumonia: No place to skimp!

1 reference

12 December 2020

PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA

1 reference

12 December 2020

IL-18 improves the early antimicrobial host response to pneumococcal pneumonia

1 reference

12 December 2020

Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?

1 reference

12 December 2020

Bacteremic pneumococcal pneumonia mortality rate. Is it really different in Sweden?

1 reference

12 December 2020

Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality

1 reference

12 December 2020

Legionella drozanskii sp. nov., Legionella rowbothamii sp. nov. and Legionella fallonii sp. nov.: three unusual new Legionella species

1 reference

12 December 2020

Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001): report from the SENTRY Antimicrobial Surveillance Program

1 reference

12 December 2020

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002).

1 reference

12 December 2020

Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation.

1 reference

12 December 2020

Clinical characteristics of Chlamydia pneumoniae infection as the sole cause of community-acquired pneumonia

1 reference

12 December 2020

Quality of care, process, and outcomes in elderly patients with pneumonia

1 reference

12 December 2020

Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study

1 reference

12 December 2020

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

12 December 2020

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

1 reference

12 December 2020

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

1 reference

12 December 2020

Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients

1 reference

12 December 2020

A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group

1 reference

12 December 2020

The best treatment for pneumonia: new clues, but no definitive answers

1 reference

12 December 2020

Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia

1 reference

12 December 2020

Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection

1 reference

12 December 2020

Effective combination therapy for invasive pneumococcal pneumonia with ampicillin and intravenous immunoglobulins in a mouse model

1 reference

12 December 2020

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia

1 reference

12 December 2020

Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997.

1 reference

12 December 2020

Infection due to Legionella species other than L. pneumophila

1 reference

12 December 2020

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

12 December 2020

Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases

1 reference

12 December 2020

Deaths in bacteremic pneumococcal pneumonia. A comparison of two populations--Huntington, WVa, and Stockholm, Sweden

1 reference

12 December 2020

Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice

1 reference

12 December 2020

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

1 reference

12 December 2020

Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia

1 reference

12 December 2020

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group

1 reference

12 December 2020

Community-acquired pneumonia requiring hospitalization: 5-year prospective study

1 reference

12 December 2020

Management of patients with community-acquired pneumonia treated in hospital in Sweden

1 reference

12 December 2020

ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract

1 reference

12 December 2020

A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections

1 reference

12 December 2020

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

1 reference

12 December 2020

Bacteraemic pneumococcal pneumonia: a continuously evolving disease

1 reference

12 December 2020

Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia

1 reference

12 December 2020

What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?

1 reference

12 December 2020

Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia

1 reference

12 December 2020

Importance of atypical pathogens of community-acquired pneumonia

1 reference

12 December 2020

Drug-resistant Streptococcus pneumoniae.

1 reference

12 December 2020

Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro

1 reference

12 December 2020

Is anti-tumor necrosis factor therapy associated with increased mortality in patients with severe sepsis caused by pneumonia?

1 reference

12 December 2020

Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.

1 reference

12 December 2020

Moraxella catarrhalis bacteraemia associated with Mycoplasma pneumoniae infection and pneumonia

1 reference

12 December 2020

An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome

1 reference

12 December 2020

Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia

1 reference

12 December 2020

The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.

1 reference

12 December 2020

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group

1 reference

12 December 2020

Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae

1 reference

12 December 2020

The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia.

1 reference

12 December 2020

Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony-stimulating factor in murine pneumococcal pneumonia.

1 reference

12 December 2020

Potential importance of Legionella species as etiologies in community acquired pneumonia (CAP)

1 reference

12 December 2020

The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection

1 reference

12 December 2020

Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia

1 reference

12 December 2020

Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia

1 reference

12 December 2020

Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain

1 reference

12 December 2020

Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children

1 reference

12 December 2020

Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland

1 reference

12 December 2020

TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia

1 reference

12 December 2020

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

1 reference

12 December 2020

Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group

1 reference

12 December 2020

Severe community-acquired pneumococcal pneumonia -- what might be done better

1 reference

12 December 2020

Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model

1 reference

12 December 2020

Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients

1 reference

12 December 2020

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

1 reference

12 December 2020

10.1016/J.IDC.2004.07.010

Identifiers

DOI

1 reference

11 August 2017

0 references

1 reference

PubMed ID

15555834